Treatment of ocular symptoms of Behçet's disease with interferon α(2a): a pilot study

Por Kotter, I., Eckstein, A., Stubiger, N., Zierhut, M.
Publicado em 1998

The use of interferon-alfa in Behçet's disease: review of the literature

Por Kötter, I, Günaydin, I, Zierhut, M, Stübiger, N
Publicado em 2003

Efficacy of recombinant human interferon-alfa2a on ocular and extra-ocular manifestations of Behçet's disease and influence on cells of the immune system: results of an open four c...

Por Kötter, I, Treusch, M, Vonthein, R, Zierhut, M, Eckstein, A, Ness, T, Günaydin, I, Grimbacher, B, Blaschke, S, Peter, HH, Stübiger, N
Publicado em 2003

Interferon as a treatment for uveitis associated with multiple sclerosis

Por Becker, M D, Heiligenhaus, A, Hudde, T, Storch-Hagenlocher, B, Wildemann, B, Barisani-Asenbauer, T, Thimm, C, Stübiger, N, Trieschmann, M, Fiehn, C
Publicado em 2005

HHV8 associated Kaposi's sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behçet's disease and complete remission of...

Por Kotter, I, Aepinus, C, Graepler, F, Gartner, V, Eckstein, A, Stubiger, N, Kaskas, B, Zierhut, M, Bultmann, B, Kandolf, R, Kanz, L
Publicado em 2001

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

Por Kötter, I, Zierhut, M, Eckstein, A K, Vonthein, R, Ness, T, Günaydin, I, Grimbacher, B, Blaschke, S, Meyer-Riemann, W, Peter, H H, Stübiger, N
Publicado em 2003